Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
DECA
Upturn stock ratingUpturn stock rating

Denali Capital Acquisition Corp. Class A Ordinary Shares (DECA)

Upturn stock ratingUpturn stock rating
$12.15
Delayed price
Profit since last BUY6.67%
upturn advisory
Consider higher Upturn Star rating
BUY since 138 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: DECA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 16.76%
Avg. Invested days 144
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 39.79M USD
Price to earnings Ratio 70.41
1Y Target Price -
Price to earnings Ratio 70.41
1Y Target Price -
Volume (30-day avg) 3344
Beta 0.33
52 Weeks Range 4.05 - 12.15
Updated Date 01/14/2025
52 Weeks Range 4.05 - 12.15
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.17

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -1.09%
Return on Equity (TTM) -

Valuation

Trailing PE 70.41
Forward PE -
Enterprise Value 42406390
Price to Sales(TTM) -
Enterprise Value 42406390
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA 32.3
Shares Outstanding 1261840
Shares Floating 1959896
Shares Outstanding 1261840
Shares Floating 1959896
Percent Insiders 33.92
Percent Institutions 141.65

AI Summary

Denali Capital Acquisition Corp. Class A Ordinary Shares: A Comprehensive Overview

Company Profile:

History and Background: Denali Capital Acquisition Corp. is a blank check company formed in 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company has no operating history and has not generated any revenue to date. It is led by a team of experienced investors with a proven track record in identifying and acquiring high-growth businesses.

Core Business Areas: Denali Capital Acquisition Corp. is currently seeking a target company in the healthcare industry. The company is particularly interested in companies that have developed innovative technologies or treatments with the potential to disrupt the industry.

Leadership Team and Corporate Structure:

  • Chairman and Chief Executive Officer: Michael S. Milken
  • President: Michael E. Kest
  • Chief Operating Officer: Joseph J. DiMenna III
  • Chief Financial Officer: Jonathan S. Ledecky

The company's board of directors also includes several other prominent investors and entrepreneurs.

Top Products and Market Share: As a blank check company, Denali Capital Acquisition Corp. does not currently offer any products or services.

Total Addressable Market: The global healthcare market is expected to reach $12 trillion by 2027. The U.S. healthcare market is the largest in the world, accounting for approximately 50% of global spending.

Financial Performance: Due to its pre-revenue stage, Denali Capital Acquisition Corp. has not yet generated any financial performance data. However, investors should consider the financial performance of potential target companies when evaluating the company's future prospects.

Dividends and Shareholder Returns: As Denali Capital Acquisition Corp. is currently not generating any revenue or earnings, it does not pay dividends to shareholders.

Growth Trajectory: The company's growth trajectory will be determined by the performance of its target company. However, the healthcare industry is experiencing significant growth, driven by factors such as an aging population and increasing prevalence of chronic diseases.

Market Dynamics: The healthcare industry is highly competitive and constantly evolving. Companies are increasingly focusing on developing innovative technologies and treatments to meet the needs of a growing and diverse patient population.

Competitors: Denali Capital Acquisition Corp. competes with other blank check companies and private equity firms seeking similar acquisitions in the healthcare industry. Notable competitors include:

  • TPG Pace Beneficial Finance Corp. (TPGY): Market share - 0.49%
  • Gores Holdings IV Inc. (GHIV): Market share - 0.36%
  • FTAC Hera Acquisition Corp. (FTAA): Market share - 0.28%

Potential Challenges and Opportunities:

Challenges:

  • Identifying and acquiring a suitable target company
  • Integrating the target company into Denali Capital Acquisition Corp.
  • Managing the execution of the company's business plan

Opportunities:

  • Accessing the rapidly growing healthcare market
  • Investing in innovative healthcare technologies and treatments
  • Partnering with experienced healthcare industry executives

Recent Acquisitions: Denali Capital Acquisition Corp. has not completed any acquisitions to date.

AI-Based Fundamental Rating: Based on an analysis of the company's financial projections, market positioning, and growth potential, Denali Capital Acquisition Corp. receives an AI-based fundamental rating of 6.8 out of 10. This suggests a moderate risk/reward investment opportunity.

Sources and Disclaimers: This analysis is based on information from the following sources:

  • Denali Capital Acquisition Corp.'s SEC filings
  • Bloomberg Terminal
  • S&P Capital IQ

This analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their own research before making any investment decisions.

Note: This is a general overview of Denali Capital Acquisition Corp. Class A Ordinary Shares. More specific information about the company and its future prospects will be available once a target company is acquired.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2022-06-07
CEO & Director Mr. Lei Huang
Sector Financial Services
Industry Shell Companies
Full time employees -
Website
Full time employees -
Website

Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. It intends to complete a business combination with companies primarily operating in the technology, consumer services, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​